Clinicians get new protocol for anti-obesity drug
Published: 2006-09-18 06:57:00
Updated: 2006-09-18 06:57:00
The Korea Food and Drug Administration (KFDA) unveiled a new set of protocols for anti-obesity drug based on some guidelines of the U.S. Food and Drug Administration and Europe's EMEA, which will be of much help to drug makers and clinicians.
The anti-obesity protocol includes indications, sel...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
